Debra Pratt, from the Cleveland Clinic Breast Health Center, writes that early detection and lifestyle changes can help save lives.
Lindsey M. Lyle, M.S., offers advice to patients with newly diagnosed myeloproliferative neoplasms.
Ilana Cass, M.D. of Cedars-Sinai Medical Center discusses some of the unknown potential side effects of preventive surgery for ovarian cancer.
New clinical trials have oncologists excited about potential new therapies for patients.
The phase 3 trial evaluating eprenetapopt plus Vidaza completed enrollment recently, and could lead to a new standard of care with positive results, according to Dr. Guillermo Garcia-Manero.
Many patients suffer from chronic pain, making opioids essential for care.
Rash is the most common side effect of cancer immunotherapies, but patients should watch for more serious issues.
For some with overwhelming medical expenses, bankruptcy can offer a solution.
An Extraordinary Healer essay honoring MICHELLE GUTIERREZ, RN, OCN [OKLAHOMA CANCER SPECIALISTS AND RESEARCH INSTITUTE, TULSA, OKLAHOMA]
A seven-year mesothelioma survivor encourages patients with cancer to be their own advocate.
Treatment options for ductal carcinoma in situ (DCIS), a precursor to breast cancer.
Lymphedema is a common side effect that may affect a cancer survivor months or even years after treatments such as surgery or radiation therapy. Here are some tips to help manage lymphedema.
An Extraordinary Healer essay honoring IVY BREWSTER, RN, OCN [CHARGE NURSE, ST. JOSEPH HEALTH, HUMBOLDT PEALS FAMILY CHEMOTHERAPY OUTPATIENT CENTER, EUREKA, CALIFORNIA]
Frederic C. Kass, from the Cancer Center of Santa Barbara, discusses the importance of a multidisciplinary team in dealing with a patient's fear.
If I ever got sick or injured I would go to the children’s hospital, but that was nothing like a real hospital where people are fighting for their life day-in and day-out. I absolutely hated it, and still do. I was in Emory Hospital visiting my dad two to three times a week for about six months, and every time I walked in that place, it just gave me the heebie-jeebies.
Beth Meagher, of Deloitte Consulting, discusses the importance of early cancer detection.
CAR-T cell therapy is generating excitement for the treatment of diffuse large B-cell lymphoma, according to an update from the JULIET trial.
Cancer—the uninvited teacher— leaves a new understanding of what’s important.
Living with the challenges of having a BRCA1 gene mutation, a woman faces a different struggle when she discovers that diagnosis was wrong.
An expert discusses a trial comparing recombinant interferon alpha-2 with hydroxyurea in patients with myeloproliferative neoplasms (MPNs).
Nubeqa plus hormone therapy improved outcomes in metastatic prostate cancer, reducing disease progression and showing a favorable safety profile.